15 
I The working group then voted 7 in favor, 0 opposed, and 1 abstention to delete 
item B of Part II. 
I; 
I 
The working group then reconsidered item C. Dr. Mahoney said side effects issues 
are addressed in Part I of the document. Ms. Areen agreed the item is redundant. 
Dr. Childress noted that only two items in Part II have been approved by the 
working group. He suggested that all of Part II might be deleted from the 
points to consider document. Mr. Capron preposed that Part II be redrafted. 
The working group agreed Part II is a necessary part of the document and the 
! conceptual substance of itons E, F, and G should be included in it. Dr. Miller 
1 said responses to all items in Part II except for item E should be optional. 
Dr. Walters preposed that the next meeting of the Working Group on Human Gene 
Therapy might be held on February 8, 11, 15, or 18, 1985. He said ccmments on 
the redraft of the introduction should be sent to ORDA. Dr. Walters said he 
would redraft the points to consider document on the basis of the ccmments 
offered at the November 16, 1985, meeting. 
Respectfully submitted. 
Eli|^beth A. Milewski, Ph.D. 
Rapporteur 
William * 
J. <3&rtland, Jr., Ph.DJ^ 
LeRoy Waj 
Chair ^ 
|.ters, Ph.D. 
[229] 
